CAS RN: 83919-23-7 | Product Number: M2354
|Size||Unit Price||Same Day||2-3 Business Days|
|Purity / Analysis Method||>98.0%(HPLC)|
|Molecular Formula / Molecular Weight||C__2__7H__3__0Cl__2O__6 = 521.43|
|Physical State (20 deg.C)||Solid|
|Condition to Avoid||Heat Sensitive|
|Reaxys Registry Number||4340538|
|PubChem Substance ID||172088987|
|Merck Index (14)||6241|
|Appearance||White to Light yellow powder to crystal|
|Purity(HPLC)||min. 98.0 area%|
|Melting point||212.0 to 216.0 °C|
|Specific rotation [a]20/D||+48.0 to +52.0 deg(C=0.5、MeOH)|
|Melting Point||214 °C(dec.)|
|Specific Rotation||50° (C=0.5,MeOH)|
|Hazard Statements||H361 : Suspected of damaging fertility or the unborn child.
|Precautionary Statements||P501 : Dispose of contents/ container to an approved waste disposal plant.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P405 : Store locked up.
A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate
In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells
Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
Progesterone receptor ligand binding pocket flexibility: crystal structures of norethindrone and mometasone furoate complexes
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.